Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tick tock … this is definitely a long hold for me .. nice to see the share price going up today ;) In the mean time, QNTA, I’m paytiently waiting $ $ $ $
Great reminders & great info!
I feel this quote is apropos :
… “An arrow can only be shot by pulling it backward. So when life is dragging you back with difficulties, it means that it’s going to launch you into something great. So just focus, and keep aiming.” …
& “know what you own” ;)
Have a great weekend everyone!
QNTA $$$ ( IMO ) Will not disappoint meanwhile … paytiently waiting
The way it looks - I don’t see why it couldn’t be used in a kitchen? Or laundry/ furnace room ? It wouldn’t look out of place in those settings and how great to have it in the house inconspicuously cleaning the air :)
QNTA $$$$
:~) cheers to all the longs here!
One day, IMO, It’ll be quite the celebration!!!
I’ll be happy to toast a blue martini to everyone when we see that day $$$
Days like today I like to read this …
They wouldn’t expand the scorpion farm if they didn’t have faith they will have orders
Patience:
Quote:
Company's goal is to be able to produce one million doses of Escozine per month in the near term. As the Company furthers its clinical trials and nutraceutical sales of Escozine, it anticipates that demand will increase exponentially. As such, it has worked with the Ministry of Environment in the DR to secure the appropriate licensing and approvals for the expansion of the reservation and the building of the lab facility.
“the Company has renewed a product registration certificate for its lead drug candidate Escozine® from the Ministry of Health in the Dominican Republic (DR). The registration enables Escozine® to be prescribed as a natural bioactive alternative medicine to be used in cancer treatments as well as a treatment for the SARS-CoV-2 (COVID-19) virus, after Medolife performed a safety and efficacy study on COVID-19. This registration in the DR through in-place trade agreements opens the door for distribution and sales in most of Latin America.”
“This registration not only validates Escozine® as a cancer therapeutic but creates an unbelievable revenue generation opportunity for our company in that the product can be off-label prescribed for treatment of COVID-19 patients as a supportive therapy where vaccination progression has been slow,” said Medolife CEO Dr. Arthur Mikaelian. “Through free trade agreements, we will be able to market Escozine to one of the largest populations in the world.
https://www.einnews.com/pr_news/540212003/medolife-rx-announces-historic-product-registration-in-dominican-republic-enabling-escozine-to-be-sold-throughout-latin-america-as-natural-alternative
QNTA Medolife rx AELIA have Experienced folks on board.. clearly those working on this believe they will be successful - why else expand the scorpion farm unless you believe in your data, and Believe you will have customers for the products (venom / escozine) .. and subsequently believe their data will garner fda approval… it’ll be great when we wake up and see the news of FDA approval.. in the mean time we have to have faith folks with the experience to get the job done are working on doing just that .. and we can do our part as investors to share the data of escozine and how it’s showing to have positive therapeutic affects at combating covid 19 .. and the data / research with various cancers and escozine is extremely promising as well!!
[{“DiArcangelo has 24 years of experience in the global biotechnology, pharmaceutical, device, and nutraceutical industries and has worked on products that have received FDA approval on 25 pharmaceutical drugs.”}]
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210623:nGNEb85TRd&default-theme=true
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/medolife-rx-announces-donation-escozine-123000631.html
https://www.prnewswire.com/news-releases/dr-arthur-mikaelian-becomes-quantas-chief-science-officer-and-is-named-to-the-board-of-directors-300872410.html
I beg to differ with you Dapper10 .. I feel they ARE doing much to move their products to market and to garner approval status from various governments … these things take time
Have you ever attempted to bring a new product to market from beginning to end that involves the fda? Or the Dominican Republic or simply an otc product ? Trying to force a governments time line is a bit like trying to change time itself …
It all takes time .. research .. funds.. and lots of hoops to jump through … QNTA is a case of (IMO) a “slow and steady wins the race” type of investment… they are making solid smart moves joining forces with good folks … this stock is more than “just a stock” it’s science, research, patents, and products … research the company you own stock in … the world can surely use a good therapeutic, the data certainly points to escozine as promising…. I’m here and happily waiting while I admire what they are building
GLTA the longs here
QNTA potential is there… the company is making the right moves to make it happen … IMO anyways ..
{ … “expansion will increase the reservation's capacity ten-fold and the Company's goal is to be able to produce one million doses of Escozine per month in the near term. As the Company furthers its clinical trials and nutraceutical sales of Escozine, it anticipates that demand will increase exponentially. As such, it has worked with the Ministry of Environment in the DR to secure the appropriate licensing and approvals for the expansion of the reservation and the building of the lab facility.”}
https://www.thefreelibrary.com/Quanta%27s+Medolife+Rx+breaks+ground+on+lab+facility+in+Dominican...-a0660105685
Agreed!!!
They’ve laid a beautiful foundation - the potential is great IMO as well … now we wait :) … for those who are impatient, research just HOW LONG the research has been going on, data collected and subsequent patents obtained … YEARS of hard work and now in more recent time some very prudent collaborations with labs, manufactures, businesses folks etc ..
there’s a lot happening here that’s worthy of praise …. While waiting I suggest folks re-read the data, the fda responses, the reviews of the products etc .. it’s easier to be patient when you know what you own ;)
I’m also Looking forward to waking up one day to the “poof” of a a new ticker :)
… Tick tock ;~$)
https://www.biospace.com/article/releases/medolife-s-therapeutic-scorpion-peptide-proves-successful-in-treating-covid-19-patients-in-dominican-republic-study/
https://www.globenewswire.com/news-release/2021/05/04/2222245/0/en/Medolife-Rx-Announces-Historic-Product-Registration-in-Dominican-Republic-Enabling-Escozine-to-Be-Sold-Throughout-Latin-America-as-Natural-Alternative-Cancer-Medicine.html
Two of many great articles … “know what you own” they say, I’m facinated by not only their science data products and patents but also by their prudent pragmatic aligning with other companies for production - brilliant chess moves if you will … for me, this stock is an investment, no secret there .. investment in the science and the future … sure, I’m hopeful to profit exponentially along with everyone else - however, I believe this company’s patented technology, escozine & many products on the horizon have the ability to help a lot of people world wide .. the scorpion farm will help reduce costs fir inventory & as well become a source of income enabling them to sell scorpion venom to other research companies as a product … QNTA Medolife rx AELIA business model is shaping up beautifully.. we just need paytience while we wait for inventory to get on the shelves…
I see lots of yelling about Promoting.. it’d be counterintuitive to blast the air waves before a product is on the shelf … the last cc it was mentioned the number of stores, also was mentioned the products that will be ordered in Mexico it was also mentioned the status of escozine in the DR being available…
I’m glad I went looking for news, as thought I’ve read the above articles before - rereading them reminds me why I bought in the first place - GLTA
QNTA $$$ In my humble opinion, staying long will pay off … imo ;)
Attendance at Hawk Event; Saw Significant Product Exposure
https://ir.quantrx.com/news-events/press-releases/detail/86/medolife-rx-recaps-successful-attendance-at-tony-hawk
Did you listen to the august webinar?
Also, dragon lady had a huge response not so long ago … qnta is an investment stock IMO not a pump and dump hype … the products are just now finding their way to the shelves … this stock is one that’s needing paytience … like the little engine that could story … this stock is low float but extremely transparent and like many global companies experienced shipping issues because of the covid back log in Chinas ability to export packaging …
This stock is a long hold IMO
https://vimeo.com/594805880/26794e1c70 Quanta Inc. (OTC: QNTA) Q2 2021 -Investor Webinar 8-24-2021
Great webinar!!! A lot of information!!! Looking forward to things getting on the shelves now that packaging arrived woohoo !!
Important $$ R/S was canceled!!
Medolife Rx cancels optional reverse split previously included in filing.
Medolife, which is a majority owned subsidiary of Quanta, cancelled an optional reverse split of shares that was included in a recent 14C filing. After consultation with legal counsel, the Board of Directors and management have concluded that it is in the best interest of the company and its shareholders to cancel the option to do reverse split of shares which was included in the 14C filed on 6/21/21. An 8K will be filed later today confirming this cancellation. "We take the responsibility we have to our shareholders very seriously and believe this to be the best course of action for our company," said Medolife CEO Dr. Arthur Mikaelian. "We held a very informative webcast on Tuesday 7/27 where we covered many of the exciting things that are happening with our company, and we highly encourage our followers to take a moment to watch it. We are in the process of building a global biotechnology company and our future could not be brighter. Thank you to the investment community for its continued support and we look forward to sharing further updates with you all soon."
https://www.thefreelibrary.com/Medolife+Rx+cancels+optional+reverse+split+previously+included+in...-a0669980921
Face book AELIA https://fb.watch/7K5nAXOkYT/
While waiting for the recording of the August conference call to be published … anyone who missed the July Cc I’ll paste it here below … I’m looking forward to relistening to last weeks cc, if any one obtains a recording before I do please post :) … while much was reinforcing what was gone over in July, some was new and promising to hear … I really like how the company is presenting things
here’s to an awesome fall withQNTA Medolife rx AELIA
I emailed them… if I hear back before any one else does I’ll post it. Last time it took a few days before the recording was available as well
No… ;)
northern Minnesota
Did you listen in full to the last few conference calls? They are on top of things quite nicely (imo). One huge problem, one that was one shared by many, was a delay in receiving their packaging materials… the shipping industry was and still is beyond bogged down due to covid … soooo the roll out was delayed … combine that with the ticker pending changing too … it would be far worse to pay for promoting a product you can’t deliver YET… than waiting patiently for the packaging to arrive then roll out when things are in place to do so … this company didn’t just open up this year … years of research have gone into developing their products… why rush now? Because a few stock holders are angry their recent ins are not flippable? Hardly … this company has made really pragmatic strategic choices which have poised them to be in position to grow up and wide .. the potential is truly mind boggling when you step back and look at the big picture …. If your unhappy it’s not fast enough for you, then either a) buy some scorpions and start your own brand b) sell the stock and chase else where or c) take a deep breath, re listen to the conference calls, educate your self on your investment and paytiently wait with the rest of us … if you sell, I’m confident many longs here will gladly take your shares off your hands ..
happy Thursday everyone!
I’m heading out to fish for walleyes with my kid …. Cheers and GLTA
Let the products have a chance to get on the shelves ;) then the PR can push them
In the mean time we wait … $$$
Agreed!!! QNTA $ ;~)
& Shine it will!!!
- IMO anyways…
Three $$$ cheers for QNTA ;)
The market will remember soon enough… and when they do I’ll be glad I’m long in this investment :)
Paytience $ ;~)
Paytiently waiting … tic toc $$$$
have a great weekend everyone :)
7:00a ET 8/5/2021 - Globe Newswire
Medolife Rx to Participate in Inaugural Tony Hawk's Vert Alert, Showcasing Breakthrough Pain Relief and Immunapen Product Lines
Mentioned: QNTA
via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated Bio-Pharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it will join the highly anticipated "Tony Hawk's Vert Alert" competition. This event will feature the most elite current skaters and returning Olympians, top skating legends, such as Tony Hawk, as well as members of the famous Bones Brigade. The event will be held at the Utah State Fairgrounds in Salt Lake City on August 27 and 28. This is the first major audience-attended skateboarding competition since the beginning of the pandemic, which is looking to attract over 8,000 attendees over the two days of competition.
Now under the Aelia brand name, this event also marks the Company's relaunch of its extremely popular polarized muscle rub products, and the expansion into additional products targeting foot pain, anti-cramp, migraine relief, sun care, burn, wound care and eczema relief. All products in the Aelia brand contain polarized active ingredients utilizing the company's patented process.
This also marks the first public introduction of the Company's highly anticipated Immunapen(TM) brand. The Immunapen(TM) product line utilizes the Company's proprietary polarized scorpion peptide formulation, which is a clinically proven immune system enhancer. The four unique homeopathic pens focus on a specific area of wellness, such as energy and focus, anti-anxiety, stress relief and general immune support. The Immunapen(TM) products target the current needs of the population during the COVID-19 pandemic.
"This will be one of our first major marketing activations alongside Tony Hawk, and we couldn't be more excited for the venue and opportunity," said Medolife CEO Dr. Arthur Mikaelian. "Working with Tony Hawk to spread the word about our Aelia product line has been a dream-come-true. He is a world-class athlete, who not only embraces the products but has a deep understanding of their benefits, especially for active lifestyle users. His audience is extremely diverse, and we look forward to supporting him and his work for years to come."
Announced in mid-June, the Company signed a product endorsement agreement with Tony Hawk, where he would help promote its line of groundbreaking, polarized cannabis-based (Hemp oil/CBD) products. The Company recently relaunched its direct-to-consumer e-commerce channelhttps://aeliastore.com/.
About Medolife Rx
Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who pioneered the unlaying polarization technology that makes the Company's portfolio of pharmaceutical and nutraceutical products so effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio company. The Company's lead clinical development programs include Escozine(R), a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. The Company has completed preclinical safety and efficacy research on Escozine(R) and is pursuing product registration and drug approval in various countries, including the United States and throughout Latin America.
Through its subsidiary QuantRx, Medolife manufactures and distributes consumer wellness products in high-impact consumer areas such as pain relief, beauty, and general wellness. QuantRx products are designed using Dr. Mikaelian's polarization technology, which applies advances in quantum biology to increase the potency of active ingredients. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste, and facilitate healthier, more sustainable consumption.
Beyond its own clinical and consumer applications, the polarization technology used by Medolife and its subsidiaries has many potential applications. From potentiating bio-ingredients, to producing more-effective carbon-trapping plants, to transformative anti-aging solutions, Medolife has the opportunity to upend how commercial and pharmaceutical products are made and increase their benefits, while decreasing their chemical concentration.
Forward-Looking Statements
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management including statements regarding the Company's expected results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "will," "should," "could," and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
Contacts:
it@medolife.com
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19
…with all the variants popping up this is a good read - or reread for some….
https://www.bloomberg.com/press-releases/2021-07-08/quanta-inc-medolife-rx-clinical-observations-demonstrates-effectiveness-of-escozine-in-complementary-use-with-covid-19
I think not a lot of trades because many who own the shares are NOT interested in selling them ?? Also, the ticker will change soon, some are waiting for that … the RS bantering and subsequently being removed slowed a few … in the mean time holding steady beats tanking … the way I see it like waiting for any holiday / event / opening day etc .. we are really in the hurry up and wait phase … I’m long with QNTA and have no interest in selling any of my shares … instead I continue to check on the news daily for anything QNTA related then busy myself with other things .. the old adage a watched pot never boils is false as it will obviously eventually boil HOWEVER it just seems like an eternity when you stare at it while waiting …
GLTA …. It’s still IMO a great bet and I know my thoughts are shared by others who are long too
… the dream is coming to fruition
like most things fda related it takes time
QNTA Medolife rx AELIA
https://www.globenewswire.com/en/news-release/2021/06/23/2251802/0/en/FDA-Accepts-COVID-19-Clinical-Study-and-Advises-on-Next-Steps-for-Pre-IND-Filing-by-Medolife-Rx.html
In the mean time while we wait for the fda I’ll be very much looking forward to Tony Hawks AELIA muscle rub PR end of August … there’s lots coming down the pipeline in regards to QNTA … $$$
New drugs take TIME … the company’s foundation is strong and they are at the pinnacle of things happening and are occurring as described in the 2 hour conference call ..
Patience will pay$ on this one IMO
For reference https://www.medicinenet.com/script/main/art.asp?articlekey=9877
So true … I seriously feel like someone knows what they are messing with and hopes to outwit and outlast the rest of us ..
I’m holding tight
Long QNTA $$$
https://www.google.com/amp/s/www.cbssports.com/olympics/news/2020-tokyo-olympics-skateboarders-kokona-hiraki-sky-brown-become-youngest-medalists-since-1936/amp/
Tony Hawk is already well known - now he’s known by so many more! With the debut of skate boarding in the (2020)Olympics this 2021 summer - this August’s skate event and PR push will more likely be much more watched as a result of happening on the heels of the Olympics. I’ve seen a similar affect at the ice rink, every Winter Olympics year there’s ALWAYS a spike in volume of kids starting lessons as well as adults coming out to enjoy the sport … In other words the timing is fantastic! IMO
QNTA Medolife Rx AELIA
Good luck to us all
Many here are long with this stock
The more I would read and research the more I tightened my grip and added shares. The science, patents, retail products, escozine, imunapen, venoms, scorpion farm… it’s truly all impressive -
the pragmatic steps being taken on all fronts is commendable for sure
The potential of this company IMO is exponential. I encourage everyone to read and search the Internet- look here on iHub at all the links shared … with covid, cancer and anxiety so much in the forefront on every continent, we can only but be hopeful this company is as successful as we believe it can be - so many can be helped as a result!! The more successful the company becomes the lower they can drive the unit price down and thus making their products available more easily to the masses!
With that,
Welcome back Sharky!
glad you jumped back in :)
**Obviously we all need to do our own DD
If you love science the research will be fun
Good luck to all
Ive attached the link to the the most recent conference below … it’s Extremely well executed & very informative, it’s long, however - very well worth the time to listen / watch in its entirety. If you’ve been researching Qnta / Medolife rx / AELIA / blue scorpion Escozine/ you’ll find some information will be things you already know - HOWEVER, the company took the time to answer and provide information in direct response to things that had been discussed on this board and questions emailed directly to them. It’s impressive how they then also subsequently removed the reverse split as well. This company is taking pragmatic steps to ensure the foundation is solid - all eyes are clearly set on long term GOAL$
Cc Link :
https://vimeo.com/580475668
“exclusive rights for investigations, production, and distribution world-wide for the venom of a unique species of scorpions indigenous to the Dominican Republic.”
https://www.biospace.com/article/releases/medolife-rx-inc-has-submitted-applications-of-their-scorpion-venom-to-help-fight-against-cancer-and-covid-19-with-the-fda-in-the-dominican-republic-/
"More importantly, all COVID-19 healthcare workers, including physicians and nurses, who took Escozine as a preventative, never tested positive" said Dr. Khalid Matalka, another leading scientist at Medolife, specializing in Cancer Therapy and Immunology. "The clinical trial results indicate that Escozine could be used as monotherapy or in combination with standard therapies against COVID-19, which will accelerate the healing from the virus. Besides, observations revealed that Escozine could be used as prevention from the COVID-19 infection."
Link to where the above except was taken from:
https://www.biospace.com/article/releases/medolife-s-therapeutic-scorpion-peptide-proves-successful-in-treating-covid-19-patients-in-dominican-republic-study/